Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Invesco Water Resources ETF (PHO)

Invesco Water Resources ETF (PHO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Photocure ASA: Update on Regulatory Classification for OAY Equipment PR Newswire - Mon Apr 13, 2:30AM CDT

OSLO, Norway , April 13, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) today announced that the U.S. Food and Drug Administration (FDA) has communicated to Photocure that it plans to issue...

PHO : 69.53 (-0.46%)
Photocure: Trials in Progress presented at the European Association of Urology (EAU) 2026 congress aim to enable a more personalized bladder cancer care pathway PR Newswire - Mon Mar 16, 11:47AM CDT

OSLO, Norway , March 16, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces two "trial in progress" presentations at the 2026 European Association of Urology congress...

PHO : 69.53 (-0.46%)
Asieris: CEVIRA Approved in China as First-in-Class Non-Invasive Therapy for Cervical Precancerous Lesions PR Newswire - Tue Mar 3, 3:52AM CST

OSLO, Norway , March 3, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated today...

PHO : 69.53 (-0.46%)
Photocure ASA: Results for the fourth quarter of 2025 PR Newswire - Wed Feb 18, 12:40AM CST

OSLO, Norway , Feb. 18, 2026 /PRNewswire/ --  Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ®  revenues of NOK 135.1 million in the fourth quarter of 2025 (Q4 2024:...

PHO : 69.53 (-0.46%)
Industrial area flooded landscape by chanwangrong via iStock
The AI Pick-and-Shovel Trade Hiding in Plain Sight: Stocks & ETFs to Invest in Water Barchart - Fri Jan 16, 6:45AM CST

As Microsoft unveils a new community-friendly face on its data center land grab, our top technical strategist explains the ‘Mad Max’-style investing thesis bubbling up under the surface.

MSFT : 431.04 (+1.62%)
CGW : 65.46 (+0.58%)
AQWA : 19.50 (+0.41%)
FIW : 108.21 (+0.11%)
PHO : 69.53 (-0.46%)
UUUU : 21.34 (+4.00%)
GEV : 1,110.08 (+11.98%)
VLTO : 89.37 (-0.35%)
XYL : 120.13 (+0.13%)
LEU : 210.70 (+10.00%)
ECL : 268.33 (-0.93%)
The impact of avoiding recurrence: New BRAVO Study abstract at SUO 2025 demonstrates Cost Neutrality in Blue Light versus White Light Cystoscopy comparison PR Newswire - Mon Dec 8, 2025

OSLO, Norway , Dec. 8, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the presentation of a health economics abstract from the BRAVO study at the Society...

PHO : 69.53 (-0.46%)
Photocure ASA: Results for the third quarter of 2025 PR Newswire - Wed Oct 29, 2025

OSLO, Norway , Oct. 29, 2025 /PRNewswire/ --  Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 134.1 million in the third quarter of 2025 (Q3 2024:...

PHO : 69.53 (-0.46%)
Photocure and Intelligent Scopes Corporation partner on development of AI for blue light cystoscopy PR Newswire - Wed Oct 15, 2025

OSLO, Norway , Oct. 15, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO ), the Bladder Cancer Company, announces that it has entered into a partnership with Intelligent Scopes Corporation...

PHO : 69.53 (-0.46%)
Photocure ASA: Results for the second quarter of 2025 PR Newswire - Wed Jul 30, 2025

OSLO, Norway , July 30, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ®  revenues of NOK 135.6 million ...

PHO : 69.53 (-0.46%)
This Simple Industrials ETF Could Turn $1,000 a Month Into $612,000 Motley Fool - Wed Mar 26, 2025

The Invesco Water Resources ETF could be a great evergreen investment.

PHO : 69.53 (-0.46%)
IVZ : 25.38 (+1.64%)

Barchart Exclusives

Diamond Prices Plunge to Lowest Levels This Century: What’s Behind the Fall? Barchart - 2 minutes ago
Diamonds may be a girl's best friend, but they're your portfolio's worst nightmare. Diamond prices are caving in, and it doesn't look like they're going to bounce back any time soon. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.